148236-54-8 Usage
Description
1,3-Diazaspiro[4.4]non-1-en-4-one,2-propyl-(9CI) is a complex organic compound characterized by its unique spirocycle structure and diaza functionality. It is a key intermediate in the synthesis of various pharmaceutical compounds due to its versatile chemical properties and reactivity.
Uses
Used in Pharmaceutical Industry:
1,3-Diazaspiro[4.4]non-1-en-4-one,2-propyl-(9CI) is used as a starting material for the preparation of azaspiro-cycloketone N-Ph indole derivatives. These derivatives are valuable in the treatment of cardiovascular diseases, as they can potentially target specific pathways involved in the development and progression of these conditions.
The compound's unique structure and reactivity make it a promising candidate for the development of novel therapeutic agents, particularly in the area of cardiovascular medicine. By leveraging its properties, researchers can design and synthesize new drugs with improved efficacy, safety, and selectivity for the treatment of various cardiovascular diseases.
Check Digit Verification of cas no
The CAS Registry Mumber 148236-54-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,4,8,2,3 and 6 respectively; the second part has 2 digits, 5 and 4 respectively.
Calculate Digit Verification of CAS Registry Number 148236-54:
(8*1)+(7*4)+(6*8)+(5*2)+(4*3)+(3*6)+(2*5)+(1*4)=138
138 % 10 = 8
So 148236-54-8 is a valid CAS Registry Number.
148236-54-8Relevant articles and documents
BIARYLMETHYL HETEROCYCLES
-
Page/Page column 191; 200, (2018/02/28)
The present invention provides compounds of Formula (I): wherein all variables are as defined in the specification, and compositions comprising any of such novel compounds. These compounds are biased agonists, or β-Arrestin agonists of the angiotensin II receptor, which may be used as medicaments.
SUBSTITUTED IMIDAZOLONE DERIVATIVES, PREPARATIONS AND USES
-
Page/Page column 38, (2010/02/16)
The present invention relates to polysubstituted imidazolone derivatives, to the pharmaceutical compositions comprising them and to the therapeutic uses thereof in the human and animal health fields. The present invention also relates to a process for preparing these derivatives.
